Predictive factors for chemoradiation-induced oral mucositis and dysphagia in head and neck cancer: a scoping review

AJ Nicol, JCF Ching, VCW Tam, KCK Liu, VWS Leung… - Cancers, 2023 - mdpi.com
Simple Summary Head and neck cancer is the seventh-most prevalent cancer worldwide.
Despite advances in treatment, many patients suffer from chemoradiation-induced oral …

Organ-sparing in radiotherapy for head-and-neck cancer: Improving quality of life

PG Hawkins, AS Kadam, WC Jackson… - Seminars in radiation …, 2018 - Elsevier
This is an overview of select studies characterizing the effect of radiation on normal tissues
in the treatment of head-and-neck cancer. Recommendations for organ-at-risk dose …

Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors

P Aggarwal, KA Hutcheson, AS Garden, FE Mott, C Lu… - Cancer, 2021 - Wiley Online Library
Background This study was conducted to identify clinicodemographic risk factors for
xerostomia among long‐term oropharyngeal cancer (OPC) survivors. Methods This cross …

Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment

MJ Windon, C Fakhry, F Faraji, T Troy, CG Gourin… - Oral oncology, 2019 - Elsevier
Introduction Little is known regarding how human papillomavirus-positive oropharyngeal
cancer (HPV-OPC) patient goals change with treatment. This study evaluates whether …

Combination of submandibular salivary gland transfer and intensity‐modulated radiotherapy to reduce dryness of mouth (xerostomia) in patients with head and neck …

RA Scrimger, H Seikaly, LJ Vos, J Harris… - Head & …, 2018 - Wiley Online Library
Background Xerostomia is a debilitating side effect of radiotherapy for head and neck
cancer. Combining surgical submandibular‐gland transfer (SMGT) with intensity‐modulated …

Comparison of molecular assays for HPV testing in oropharyngeal squamous cell carcinomas: a population-based study in Northern Ireland

SG Craig, LA Anderson, M Moran, L Graham… - … Biomarkers & Prevention, 2020 - AACR
Background: Determination of human papillomavirus (HPV) status has become clinically
relevant for patient stratification under UICC TNM8 staging. Within the United Kingdom, a …

[HTML][HTML] Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients

J Hedström, L Tuomi, C Finizia, C Olsson - Clinical and Translational …, 2019 - Elsevier
Background and purpose Dysphagia is a common, severe and dose-limiting toxicity after
oncological treatment of head and neck cancer (HNC). This study aims to investigate …

Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models

X Zhang, W Zheng, S Huang, LI Haojiang, BI Zhisheng… - Oral Oncology, 2024 - Elsevier
Objectives This study aimed to integrate radiomics and dosiomics features to develop a
predictive model for xerostomia (XM) in nasopharyngeal carcinoma after radiotherapy. It …

Initial feasibility and acute toxicity outcomes from a phase 2 trial of 18F-Fluorodeoxyglucose positron emission tomography response-based De-escalated definitive …

SG Allen, BS Rosen, M Aryal, Y Cao… - International Journal of …, 2023 - Elsevier
Purpose 18 F-Fluorodeoxyglucose positron emission tomography (FDG-PET) parameters
are prognostic of oncologic outcomes in human papillomavirus–associated oropharyngeal …

[HTML][HTML] Head and neck radiation therapy patterns of practice variability identified as a challenge to real-world big data: Results from the Learning From Analysis of …

A Caissie, M Mierzwa, CD Fuller, M Rajaraman… - Advances in radiation …, 2023 - Elsevier
Purpose Outside of randomized clinical trials, it is difficult to develop clinically relevant
evidence-based recommendations for radiation therapy (RT) practice guidelines owing to …